Genix Pharmaceuticals Corporation (TSXV:GENX)

Genix Pharmaceuticals Revenue

Genix Pharmaceuticals had revenue of 68.00 CAD in the twelve months ending July 31, 2025, down -98.72% year-over-year. In the fiscal year ending October 31, 2024, Genix Pharmaceuticals had annual revenue of 4.05K, down -67.19%.

• Revenue (ttm): 68.00
• Revenue Growth: -98.72%
• P/S Ratio: 18,007.10
• Revenue / Employee: 0.02
• Employees: 4,000
• Market Cap: 1.22M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2024	4.05K	-8.30K	-67.19%
Oct 31, 2023	12.35K	-	-
Oct 31, 2022	-	-	-
Oct 31, 2021	-	-	-
Oct 31, 2020	-	-	-
Oct 31, 2019	137.40K	-282.56K	-67.28%
Oct 31, 2018	419.96K	-1.86K	-0.44%
Oct 31, 2017	421.82K	-502.87K	-54.38%
Oct 31, 2016	924.70K	273.84K	42.07%
Oct 31, 2015	650.86K	277.73K	74.43%
Oct 31, 2014	373.13K	-221.87K	-37.29%
Oct 31, 2013	595.00K	-8.11K	-1.34%
Oct 31, 2012	603.11K	29.83K	5.20%
Oct 31, 2011	573.28K	284.73K	98.67%
Oct 31, 2010	288.56K	-150.79K	-34.32%
Oct 31, 2009	439.35K	167.95K	61.88%
Oct 31, 2008	271.40K	70.89K	35.35%
Oct 31, 2007	200.51K	-719.75K	-78.21%
Oct 31, 2006	920.26K	-624.48K	-40.43%
Oct 31, 2005	1.54M	-	-